About Us

By Editorial Team
At One Day Advisor, we are a team of senior experienced executives from corporate backgrounds within different industries we are a team of seasoned executives from diverse industries who have come together, to leverage on our experience and our relationships in different parts of the world and industries, with one goal in mind: to enhance shareholders’ value for our clients.

Our specialities are in mergers and acquisitions, raising private equity and debt, as corporate doctors turning around businesses and implementing strategies wherein growth is the end goal.

Everything we do is about creating sustainable businesses and helping successful companies reach full potential by connecting, owners of businesses to capital, markets and strategic partners.

One Day Media Group is #1 on Bing and DuckDuckGo search engines for the following keywords:
  • Top 10 Pharmaceutical Companies by Revenue
  • Top 10 Drugs by Worldwide Sales
  • Top 10 Cancer Drug Companies

How We Add Value

Capital Access: We facilitate private equity and debt solutions tailored to your business needs.



Capital (Private Equity and Debt, if necessary)


Strategic Relationships: Leveraging high-level connections with industry leaders across the Asia Pacific region, we open doors to new opportunities.



High level relationships with industry leaders within the Asia Pacific region


Industry Expertise: Our collective experience encompasses sectors such as healthcare, property development, food and beverage, banking and corporate finance, telecommunications, IT, and more.



Whatever the industry, we believe success comes from a combination of:
  • Affordable and timely capital
  • Proper planning and sound strategies
  • Committed drivers of businesses and team building
  • Alignment of goals between shareholders and management
  • Maintaining barriers to entry
  • Mitigating risks

Our Approach



We objectively assess each opportunity, offering insightful advice to drive growth. By combining financial acumen, capital access, and strategic relationships, we craft sustainable business models that thrive.

Our Track Record

With over 180 years of combined experience, our principal partners and associates have successfully executed numerous mergers and acquisitions, joint ventures, asset transactions, and business turnarounds across various sectors. Our global footprint includes Malaysia, the UK, the US, China, South Korea, Hong Kong, the Philippines, Singapore, Australia, New Zealand, Sri Lanka, India, Thailand, and Indonesia.

"A GLOBAL BUSINESS NETWORK HELPING SUCCESSFUL COMPANIES REACH FULL POTENTIAL"

Partner with Us

If you have a project poised for growth and seek capital infusion, market expansion, or strategic partnerships, let's explore how we can collaborate to elevate your business. Contact us today to discuss your ideas and discover how One Day Advisor can help you achieve your goals.

If you find yourself with a project requiring any of the below, contact us.

Capital (Equity or Debt or both) | Growth beyond organic growth | Disposal of an asset | Company or business turnaround or restructuring plan | SPACs (Special Purpose Acquisition Companies) | Joint Venture | Strategic Alliance

Comments

Post a Comment

Pages

Popular posts from this blog

Top 10 Pharmaceutical Companies by Revenue and Market Cap in 2025 (October Edition)

By
Image
The pharmaceutical industry continues to show robust performance in Q3 2025, with key players reporting strong sales driven by oncology, immunology, and metabolic drugs. Eli Lilly maintains its lead in market capitalization, fueled by high demand for its GLP-1 treatments Mounjaro and Zepbound, with projected full-year revenue growth of around 32%. Johnson & Johnson reported Q3 sales of $24.0 billion, up 6.8%, and raised its 2025 sales outlook. Roche achieved 7% sales growth in the first nine months to CHF 45.9 billion ($52.8 billion), raising its full-year guidance to mid-single-digit growth. Other top companies like AstraZeneca, Novartis, and Vertex reported double-digit growth in key segments. Challenges persist, including patent expirations and biosimilar competition, but new approvals and acquisitions signal continued innovation. This edition updates data with Q3 2025 figures where available. Credit:  fiercepharma.co...
Read more

Top 10 Pharma Companies by Market Cap in 2025

By
Image
Here are the top 10 pharmaceutical companies by market cap. The pharmaceutical industry remains robust amid evolving market dynamics, driven by innovation, strategic expansions, and shifting healthcare policies. This 2025 update integrates the first half's (H1) financial results to provide readers with a clear snapshot of leading companies’ performance and trajectory. In contrast, most of the other top 10 pharmaceutical companies are expected to see more moderate revenue growth, generally in the range of 6% to 9% by the end of 2025. This reflects steady but less dramatic expansion compared to Eli Lilly’s exceptional performance ( 4 ). Source: CompaniesMarketCap.com Lilly—boosted by sales of its diabetes and obesity drugs Moujaro and Zepbound— projects  its sales to fall between $58 billion and $61 billion. Meanwhile, Novo—which also has been powered by sales...
Read more

Top 10 Stock Picks for November 2025: Best Stocks to Buy Now for Growth Amid AI Boom, Tariff Concerns, and Fed Rate Cuts

By
Image
Introduction The stock market in November 2025 continues to navigate a complex landscape shaped by President Trump's tariff policies, which have dialed back slightly but still contribute to persistent inflation around 3.5% and economic uncertainty. Despite these headwinds, the Federal Reserve's ongoing rate cuts—totaling 0.75% so far this year—have fueled a market melt-up, with the S&P 500 rallying 36% over the past six months on strong corporate earnings and AI optimism. Gold prices have surged past $4,000 an ounce as a hedge, while cryptocurrencies hit new highs. However, warnings of an AI bubble abound, with elevated valuations in tech giants signaling potential risks that may not materialize until the Fed tightens policy. Drawing from analyses by Zacks, Forbes, ValueSense, US News, and Morningstar, this list highlights 10 high-conviction picks emphasizing AI-driven growth, resilient sectors, and undervalued opportunities for diversification in a bifurcated economy. Top ...
Read more

Top 10 Gold and Silver ETF Picks for November 2025: Best Investments for Hedging Amid Inflation, Tariff Adjustments, and Fed Easing

By
Image
Introduction As November 2025 unfolds, the stock market navigates a complex and evolving landscape shaped by President Trump's adjusted tariff policies, which have moderated slightly but still contribute to persistent inflation around 3.4% and economic uncertainty. Despite these headwinds, the Federal Reserve's ongoing rate cuts—totaling 0.875% so far this year—have ignited a powerful market melt-up, with the S&P 500 rallying 39% over the past six months on strong corporate earnings and AI optimism.  Gold prices have surged past $4,150 an ounce as a hedge and inflation buffer, while cryptocurrencies continue to hit new highs and maintain their upward trajectory. However, warnings of an AI bubble abound and linger, with elevated valuations in tech giants signaling potential risks that may not materialize until the Fed tightens policy or if policies change. Silver prices have risen above $55 per ounce, fueled by industrial demand in solar and electronics. Drawing from analyse...
Read more

Top 10 Stocks and ETFs Poised to Outperform in November 2025

By
Image
As November 2025 unfolds, the stock market navigates a complex and evolving landscape shaped by President Trump's adjusted tariff policies, which have moderated slightly but still contribute to persistent inflation around 3.4% and economic uncertainty. Despite these headwinds, the Federal Reserve's ongoing rate cuts—totaling 0.875% so far this year—have ignited a powerful market melt-up, with the S&P 500 rallying 39% over the past six months on strong corporate earnings and AI optimism. Gold prices have surged past $4,150 an ounce as a hedge and inflation buffer, while cryptocurrencies continue to hit new highs and maintain their upward trajectory. However, warnings of an AI bubble abound and linger, with elevated valuations in tech giants signaling potential risks that may not materialize until the Fed tightens policy or if policies change. Drawing from analyses by Zacks, Forbes, ValueSense, US News, Morningstar, Bankrate, and Motley Fool, this list highlights 10 high-conv...
Read more

Top XRP ETFs to Watch in 2025: Dominating Holdings, Low Fees, and Performance Insights

By
Image
As the cryptocurrency market matures in 2025, XRP ETFs have emerged as essential instruments for investors seeking regulated and accessible exposure to this dynamic digital asset. With a growing variety of futures-based and physically backed spot ETFs now available across major markets like the U.S., Canada, and Europe, understanding the nuances of these products—including their fee structures, holdings, and performance—is crucial for making informed investment decisions. This article highlights the top XRP ETFs to watch in 2025, providing deep insights into their dominating holdings, low fees, and recent market impact, all organized in a clear list format for easy navigation. Whether you are a long-term investor or an active trader, this guide will help you identify opportunities and risks in the evolving XRP ETF landscape. Update:  Top Bitcoin, Ethereum, and XRP ETFs to Watch in October 2025 : Updated Performance, AUM, and Investment Insights 1. Leading XRP ETFs in 2025 ProSha...
Read more

Top 10 Food Companies by Revenue (2025)

By
Image
Based on the most recent 2025 revenue data, here are the top 10 food companies ranked by revenue: Top 10 Food Companies by Revenue (2025) 1. Nestlé (Switzerland) Revenue:  $101.54 billion Key Brands: Nescafe, KitKat, Maggi, Purina, Waters Notes:  World's largest food company, with a diverse portfolio including bottled water, coffee, frozen foods, and nutrition products. Nestlé Health Science (NHSc), a subsidiary of Nestlé, owns a variety of supplement brands. Some of the most notable ones include: Garden of Life, Vital Proteins, Pure Encapsulations, Wobenzym, Douglas Laboratories, Persona Nutrition, Genestra, Orthica, Minami, AOV, Klean Athlete, Nature's Bounty, Solgar, Osteo Bi-Flex, and Sundown. 2. Ahold Delhaize  (Netherlands) Revenue:  $96.22 billion Notes: Major global food retailer and distributor. 3. PepsiCo (USA) Revenue: $91.52 billion Key Brands: Pepsi, Lay's, Gatorade, Tropi...
Read more

AI Demand Drives SSD & Memory Shortages: Prices Set to Rise for a Decade (2025)

By
Image
Nearly every analyst firm and memory maker is now warning of looming NAND and DRAM shortages that will send SSD and memory prices skyrocketing over the coming months and years, with some even predicting a shortage that will last a decade. The shortages are becoming impossible to ignore, and warnings from the industry are growing dire, as the voracious appetite of AI data centers begins to consume the lion's share of the world's memory and flash production capacity. For the better part of two years, storage upgrades have been a rare bright spot for PC builders. SSD prices cratered to all-time lows in 2023 , with high-performance NVMe drives selling for little more than the cost of a modest mechanical hard disk. DRAM followed a similar trajectory, dropping to price points not seen in nearly a decade. In 2024, the pendulum swung firmly in the other direction, with prices for both NAND flash and DRAM starting to climb. The shift has its roots in the cyclical na...
Read more

Top Gold ETFs to Watch in Late 2025: Best Picks for Strong Returns and Low Costs

By
Image
As of November 2025, gold prices have surged to new all-time highs, trading around $4,000 per ounce after rallying over 50% year-to-date amid persistent inflation, geopolitical tensions, and strong central bank demand. This has propelled gold ETFs to exceptional performance, with physical gold funds delivering 40-60% YTD returns and mining-focused ETFs often exceeding 100%.  Top gold ETFs span U.S., European, and Chinese markets, providing options for physical gold exposure or leveraged mining plays. This updated overview incorporates the latest performance data, trends, and forecasts as of early November 2025, highlighting shifts since mid-year. U.S. Gold ETFs U.S. gold ETFs remain dominant, with physical funds like GLD and IAU offering stability, while mining ETFs like GDX provide amplified returns amid expanding miner margins. 1. SPDR Gold MiniShares Trust (GLDM) Type : ETF Sector : Physical Gold Performance : YTD ~+51% AUM : $17.3B Reason : Cost-effective physical go...
Read more

Top 10 Stocks and ETFs Poised to Outperform in September 2025

By
Image
With the Federal Reserve initiating its rate-cutting cycle on September 17, 2025, by lowering rates by 25 basis points, markets are shifting toward sectors sensitive to lower borrowing costs, such as technology, real estate, small caps, and consumer discretionary. This environment favors growth-oriented assets and those with floating-rate debt exposure. Based on recent analyses from financial experts, we've compiled a forward-looking list of 10 recommendations (a mix of 10 stocks and 10 ETFs) expected to benefit from these dynamics through the end of September and into Q4. Selections prioritize high-conviction picks with strong upside potential, momentum, and sector tailwinds. Update: Top 10 Stocks and ETFs Poised to Outperform in October 2025 Below, we've incorporated recent performance data (YTD) for context on their trajectory. Top 10 Stocks to Watch in September 2025 These stocks have shown strong year-to-date performance in 2025, indicating potential to continue outperform...
Read more